Responses
Spondyloarthritis
Original research
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.